Open AccessAnaphylaxis after Moderna COVID-19 vaccine
Author(s) -
Jeremy Mayfield,
Sumedha Bandi,
Latha Ganti,
Jose Rubero
Publication year - 2021
Publication title -
therapeutic advances in vaccines and immunotherapy
Language(s) - English
Resource type - Journals
eISSN - 2515-1363
pISSN - 2515-1355
DOI - 10.1177/25151355211048418
Subject(s) - medicine , anaphylaxis , covid-19 , auscultation , presentation (obstetrics) , throat , emergency department , dermatology , pediatrics , allergy , immunology , surgery , nursing , disease , infectious disease (medical specialty)
The authors of this article report on a case of a patient who presented to the emergency department (ED) in anaphylaxis after receiving the Moderna® COVID-19 vaccine. The patient was hypoxic, with diffuse wheezing bilaterally to auscultation, flush skin, swollen face, and the feeling of her throat closing. Anaphylaxis can have wide range of presentation, the key is recognizing the symptoms and treating early. The incidence of anaphylaxis from COVID-19 vaccine is not well documented to date.